Beryl Drugs Ltd — Important, 06-04-2026: Company Update

Beryl Drugs Limited has filed its compliance reports for the quarter ended March 31, 2026. The company confirmed that shareholder requests for share dematerialisation and rematerialisation were processed efficiently. It also certified that both physical and electronic share transfer facilities were properly maintained for the entire year ending March 31, 2026, ensuring smooth investor transactions. Additionally, the company declared non-applicability for certain regulatory requirements, indicating they do not pertain to its current operations. These filings confirm routine adherence to essential operational and governance standards.